3-iodobenzylguanidine has been researched along with fluorodeoxyglucose f18 in 107 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (6.54) | 18.2507 |
2000's | 38 (35.51) | 29.6817 |
2010's | 55 (51.40) | 24.3611 |
2020's | 7 (6.54) | 2.80 |
Authors | Studies |
---|---|
Donath, A; Pittet, N; Polla, BS; Slosman, DO | 1 |
Deeb, GM; Francis, IR; Koeppe, RA; Lloyd, RV; Shulkin, BL; Thompson, NW | 1 |
Baro, ME; Castle, VP; Dole, MG; Hutchinson, RJ; Mitchell, DS; Rawwas, JB; Shulkin, BL; Sisson, JC; Ungar, DR; Wieland, DM | 1 |
Macfarlane, DJ; Murphy, K; Shulkin, BL; Wolf, GT | 1 |
Castle, VP; Hutchinson, RJ; Shapiro, B; Shulkin, BL; Sisson, JC; Yanik, GA | 1 |
Einert, A; Laubenberger, JJ; Moser, E; Nitzsche, EU; Simon, GH | 1 |
Francis, IR; Shapiro, B; Shulkin, BL; Sisson, JC; Thompson, NW | 1 |
Bomanji, JB; Costa, DC; Ell, PJ; Le Rest, C; Townsend, CE; Visvikis, D | 1 |
Klain, M; Mainolfi, C; Maurea, S; Salvatore, M; Ziviello, M | 1 |
Lawson, MA | 1 |
Fawwaz, RA; van Heertum, RL | 1 |
Cheung, NK; Kramer, K; Kushner, BH; Larson, SM; Yeung, HW | 1 |
Fukuchi, K; Hayashida, K; Horita, Y; Inenaga, T; Ishida, Y; Suzuki, Y | 1 |
Bombardieri, E; Chiti, A; De Deckere, E; Maccauro, M; Savelli, G | 1 |
Hasegawa, S; Iino, K; Ikematsu, Y; Ishizu, K; Kida, H; Nishiwaki, Y; Okawada, T; Ozawa, T; Taniguchi, K; Taniguchi, M; Torizuka, T; Uchimura, M; Waki, S | 1 |
Blake, M; Bushnell, D; Graham, MM; Johnson, J; Juweid, ME; Madsen, M; Menda, Y; O'Dorisio, MS | 1 |
Berner, U; Diehl, M; Döbert, N; Graichen, S; Grünwald, F; Hamscho, N; Menzel, C; Risse, JH | 1 |
Behr, TM; Döbert, N; Gotthard, M; Grünwald, F; Hamscho, N; Kranert, WT; Menzel, C; Zaplatnikov, K | 1 |
Caracò, C; Klain, M; Mainolfi, C; Maurea, S; Salvatore, M | 1 |
Eriksson, B; Oberg, K | 1 |
Bley, TA; Brink, I; Hoegerle, S; Klisch, J | 1 |
Ezuddin, S; Fragkaki, C | 1 |
Ayala, A; Carrasquillo, JA; Chen, CC; Del Corral, P; Ilias, I; Mamede, M; Pacak, K; Whatley, M | 1 |
Byrd, DR; Kinahan, PE; Krohn, KA; Link, JM; Mankoff, DA; Mann, GN; Pham, P; Pickett, CA | 1 |
Avram, AM; Fig, LM; Gross, MD | 1 |
Ishii, K; Itokawa, K; Kawai, N; Shimazu, K; Tamura, N | 1 |
Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Kozupa, A; Lenders, JW; Ling, A; Pacak, K; Solis, D; Timmers, HJ | 1 |
Carrasquillo, JA; Chen, CC; Hadi, M; Pacak, K; Whatley, M | 1 |
Balan, KK; Brown, MJ; Chatterjee, K; Gurnell, M; Mackenzie, IS; Simpson, H | 1 |
Fujishita, M; Fujishita, T; Kishida, M; Kobayashi, M; Maruyama, M; Miyabayashi, K; Mizushima, Y; Shinoda, C; Taki, H | 1 |
Juergens, KU; Kies, P; Rahbar, K; Stegger, L; Weckesser, M | 1 |
Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Kozupa, A; Lazúrová, I; Ling, A; Pacak, K; Reynolds, JC; Timmers, HJ; Whatley, MA; Widimsky, J; Zelinka, T | 1 |
Barlier, A; Colavolpe, C; De Micco, C; Henry, JF; Morange, I; Mundler, O; Niccoli-Sire, P; Palazzo, FF; Sebag, F; Taïeb, D; Tessonnier, L | 1 |
Azevedo, JC; Barbirato, GB; Boechat, Y; Cabral, H; Correa, PL; Dohmann, HF; Felix, RM; Manhães, AC; Mendes, MH; Mesquita, CT; Schmidt, GJ; Schmidt, SL; Tolentino, JC | 1 |
Imabayashi, E; Kuji, I; Matsuda, H; Minagawa, A; Miyauchi, T | 1 |
Amanuma, M; Arisaka, Y; Endo, K; Higuchi, T; Nakajima, T; Oriuchi, N; Takano, A; Taketomi-Takahashi, A; Tsushima, Y | 1 |
Cammilleri, S; Colavolpe, C; Coze, C; Guedj, E; Mundler, O; Taïeb, D | 1 |
Angeletti, G; Avenia, N; Caracò, C; Chiofalo, MG; Colao, A; Faggiano, A; Ferolla, P; Grimaldi, F; Lombardi, G; Mozzillo, N; Pezzullo, L; Santeusanio, F | 1 |
Barnes, N; Kokai, G; Losty, P; Mc Dowell, H | 1 |
Bareiss, P; Blondet, C; Cimarelli, S; Constantinesco, A; De Poli, F; Imperiale, A; Jesel, L; Morel, O; Ohlmann, P; Sauer, F; Trinh, A | 1 |
Tenenbaum, F | 1 |
Furman, WL; Gelfand, MJ; Salisbury, S; Sharp, SE; Shulkin, BL | 1 |
Enomoto, D; Fukuoka, T; Higaki, J; Irita, J; Jotoku, M; Kurata, M; Miyoshi, K; Nagao, T; Okura, T | 1 |
Carlson, D; Groshen, S; Han, MM; Hawkins, R; Jackson, HA; Mari Aparici, C; Maris, J; Matthay, KK; Quach, A; Taggart, DR; Villablanca, JG; Ye, W | 1 |
Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Havekes, B; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M | 1 |
Heston, TF | 1 |
Bhatla, D; Nguyen, NC; Osman, MM | 1 |
Ayala-Ramirez, M; Callender, GG; Chuang, HH; Goodarzi, M; Jimenez, C; Kupferman, ME; Perrier, ND; Rich, TA; Trent, J | 1 |
Chew, SL | 1 |
Binderup, T; Federspiel, B; Hansen, CP; Højgaard, L; Kjaer, A; Knigge, U; Loft, A; Mortensen, J; Pfeifer, A | 1 |
Haba, R; Imachi, H; Ishida, T; Kakehi, Y; Kikuchi, F; Kushida, Y; Miyai, Y; Murao, K; Ohyama, T | 1 |
Llamas, JM; Mena, LM; Moreno, MJ; Muros, MA; Palacios, H; Santiago, A | 1 |
Arai, H; Fujishiro, H; Higashi, S; Iseki, E; Kasanuki, K; Murayama, N; Sato, K; Suzuki, M; Yamamoto, R | 1 |
Aldridge, M; Almuhaideb, A; Bomanji, JB; Gaze, MN; Papathanasiou, ND; Sullivan, K; Waddington, W | 1 |
Albert, MH; Bartenstein, P; Coppenrath, E; Melzer, HI; Pfluger, T; Schmid, I; Tudball, C; von Schweinitz, D | 1 |
Arisaka, Y; Endo, K; Higuchi, T; Nakazawa, A; Oriuchi, N | 1 |
Adams, KT; Alexopoulos, DK; Chen, CC; King, KS; Lando, H; Ling, A; Pacak, K; Patronas, N; Reynolds, JC; Stratakis, CA; Whatley, MA; Xekouki, P | 1 |
Gelfand, MJ; Sharp, SE; Shulkin, BL | 1 |
Bernardi, S; Bertolotto, M; De Marchi, S; Fabris, B; Finato, N; Grimaldi, F; Proclemer, A; Sabato, N | 1 |
Fujishiro, H; Iseki, E; Kasanuki, K; Murayama, N; Ota, K; Sato, K; Suzuki, M | 1 |
Amanuma, M; Higuchi, T; Nakano, S; Taketomi-Takahashi, A; Tsushima, Y | 1 |
Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; King, KS; Ling, A; Pacak, K; Rao, JU; Timmers, HJ; Wesley, RA; Whatley, M | 1 |
Chang, HH; Hsu, WM; Huang, SF; Jou, ST; Lee, H; Lee, YL; Liao, YF; Lin, DT; Lin, KH; Liu, YL; Lu, MY; Luo, TY; Shen, LH; Tzen, KY; Wu, PY; Yang, YL | 1 |
Admiraal, WM; Bahler, L; Hoekstra, JB; Holleman, F; Soeters, MR; Verberne, HJ | 1 |
Biermann, M; Fasmer, KE; Johnsen, B; Reitan, BC; Rosendahl, K; Schwarzlmüller, T | 1 |
Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
Cascini, GL; Cuccurullo, V; Mansi, L; Rotondo, A; Tamburrini, O | 1 |
Gelfand, MJ; Parisi, MT; Sharp, SE; Shulkin, BL; Yanik, GA | 1 |
Cabria, M; Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G | 1 |
Codreanu, I; Zhuang, H | 1 |
Casey, R; Maher, M; Moore, M; O'Halloran, D; Prendeville, S; Slattery, D | 1 |
Admiraal, WM; Hoekstra, JB; Holleman, F; Karamat, FA; Soeters, MR; Verberne, HJ | 1 |
Bergestuen, DS; Khan, MS; Kim, MK; Oberg, K; Rinke, A; Salazar, R; Thirlwell, C; Toumpanakis, C | 1 |
Kabuki, S; Kimura, H; Kubo, H; Tanimori, T | 1 |
Basely, M; Boret, H; Bussy, E; Cambefort, P; Cimarelli, S; D'Aranda, E; Dagain, A; Desse, N; Esnault, P; Goutorbe, P; Habib, G; Jego, C; Lacroix, G; Meaudre, E; Pons, F; Prunet, B; Veyrieres, JB | 1 |
Ahn, Y; Bom, HS; Cho, JG; Cho, JY; Chong, A; Hong, YJ; Jang, SY; Jeong, HC; Jeong, IS; Jeong, MH; Kang, JC; Kim, HK; Kim, J; Kim, JH; Kim, JM; Kim, KH; Kim, MS; Kim, SS; Lee, KH; Lim, KS; Oh, SG; Park, DS; Park, HW; Park, JC; Park, KH; Ryu, SH; Sim, DS; Song, HC; Yoon, HJ; Yoon, NS | 1 |
Makis, W; McCann, K; McEwan, AJ | 1 |
Al Ghuzlan, A; Baudin, E; Berdelou, A; Bidault, F; Borget, I; Caramella, C; Déandreis, D; Deschamps, F; Dumont, F; Gimenez-Roqueplo, AP; Guillaud Bataille, M; Hartl, D; Leboulleux, S; Lepoutre-Lussey, C; Lumbroso, J; Nascimento, C; Schlumberger, M | 1 |
Bandgar, T; Kasaliwal, R; Lila, A; Malhotra, G; Shah, NS | 1 |
Baba, S; Hida, T; Honda, H; Kamitani, T; Kawanami, S; Kohashi, K; Nagao, M; Nakamura, K; Oda, Y; Sonoda, H; Takashima, Y; Yabuuchi, H; Yamasaki, Y; Yonezawa, M | 1 |
Agarwala, S; Bakhshi, S; Bal, C; Bhatnagar, V; Dhull, VS; Kumar, R; Kundu, P; Patel, C; Sharma, P | 1 |
Angelousi, A; Kaltsas, G; Kassi, E; Zografos, G | 1 |
Hicks, RJ; Pacak, K; Taïeb, D | 1 |
de Labriolle-Vaylet, C; Jehanno, N; Michon, J; Montravers, F; Wartski, M | 1 |
Admiraal, WM; Bahler, L; Hoekstra, JB; Holleman, F; Soeters, MR; Stok, WJ; Verberne, HJ | 1 |
Servaes, S; Zhang, W; Zhuang, H | 1 |
Hida, A; Kameyama, M; Morooka, M; Sato, K; Takeuchi, S | 1 |
Bahler, L; Deelen, JW; Hoekstra, JB; Holleman, F; Verberne, HJ | 1 |
Ebbehoj, A; Gormsen, LC; Poulsen, PL; Søndergaard, E | 1 |
Arnous, MM; Lan, X; Sun, X | 1 |
Charalampopoulos, A; Farrugia, FA; Martikos, G; Misiakos, E; Surgeon, C; Tzanetis, P; Zavras, N | 1 |
Pfluger, T; Piccardo, A | 1 |
Bagatell, R; Berthold, F; Boubaker, A; Brock, P; Burchill, S; Cohn, SL; Ladenstein, R; Lindwasser, OW; London, WB; Maris, JM; Matthay, KK; McHugh, K; Nuchtern, JG; Park, JR; Pearson, AD; Schleiermacher, G; Seibel, NL; Valteau-Couanet, D; Villablanca, JG | 1 |
Huo, L; Jing, H; Li, F; Li, W; Wang, L; Wang, Z; Zhang, J | 1 |
Servaes, SE; Tolboom, N; Zhuang, H | 1 |
Ahmadzadehfar, H; Alexander, N; Baruchel, S; Shammas, A; Vali, R | 1 |
Christoffersen, C; Ellingsgaard, H; Enevoldsen, LH; Gammeltoft, S; Hovmand, NL; Jennum, PJ; Kjær, A; Stallknecht, BM; Suetta, C; Tindborg, M | 1 |
Koyanagawa, K; Manabe, O; Naya, M; Oyama-Manabe, N; Tamaki, N | 1 |
Ansquer, C; Drui, D; Kraeber-Bodéré, F; Lugat, A; Mirallié, E | 1 |
Arai-Okuda, H; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Tani, R; Yamamoto, Y | 1 |
Cottereau, AS; Dousset, B; Garcia, C; Libe, R; Tenenbaum, F | 1 |
Ahmed, AM; Corwin, M; Elsayes, KM; Klimkowski, S; Korivi, BR; Mahmoud, HS; Menias, CO; Salem, U; Shaaban, AM; Wang, MX | 1 |
Drubach, L; DuBois, SG; Janeway, KA; Kamihara, J; Krokhmal, AA; Kwatra, N; Voss, SD; Weldon, CB | 1 |
Kachanov, D; Kailash, C; Likar, Y; Shamanskaya, T; Yadgarov, M | 1 |
Hahner, S; Hartrampf, PE; Schirbel, A; Werner, RA | 1 |
Abe, T; Hirata, K; Kimura, R; Kudo, K; Shinohara, N; Takenaka, J; Uchiyama, Y; Watanabe, S | 1 |
Carli, G; Janzen, A; Kogan, RV; Leenders, KL; Meles, SK; Oertel, WH; Perani, D; Sittig, E | 1 |
22 review(s) available for 3-iodobenzylguanidine and fluorodeoxyglucose f18
Article | Year |
---|---|
The role of nuclear medicine in the evaluation of pancreatic disease.
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Octreotide; Pancreatic Diseases; Pancreatic Neoplasms; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed | 2001 |
Nuclear medicine imaging of neuroendocrine tumours.
Topics: 3-Iodobenzylguanidine; 5-Hydroxytryptophan; Antibodies, Monoclonal; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Levodopa; Neuroendocrine Tumors; Pancreatic Neoplasms; Radiopharmaceuticals; Somatostatin; Tomography, Emission-Computed | 2001 |
Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Neoplasm Staging; Nuclear Medicine; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin | 2005 |
Imaging of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
Adrenal gland scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Glands; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Hyperaldosteronism; Incidental Findings; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography; Virilism | 2006 |
[Adrenal incidentaloma and nuclear medicine examination].
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Pediatrics: diagnosis of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Animals; Bone and Bones; Child; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Pediatrics; Radiography; Radionuclide Imaging; Radiopharmaceuticals | 2011 |
Is there a role for PET-CT and SPECT-CT in pediatric oncology?
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Fluorodeoxyglucose F18; Humans; Infant; Neoplasms; Pediatrics; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2013 |
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
Bone metastases radiopharmaceuticals: an overview.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Choline; Dihydroxyphenylalanine; Diphosphonates; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Radioimmunodetection; Radiopharmaceuticals; Sodium Fluoride; Somatostatin; Technetium; Thymidine; Tomography, Emission-Computed, Single-Photon | 2013 |
Functional-metabolic imaging of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Central Nervous System Neoplasms; Child; Child, Preschool; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Medical Oncology; Neuroblastoma; Prognosis; Radionuclide Imaging; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
PET/CT imaging in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Central Nervous System Neoplasms; Child; Child, Preschool; Dihydroxyphenylalanine; Ephedrine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Models, Biological; Models, Chemical; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Tomography, X-Ray Computed | 2013 |
Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Magnetic Resonance Imaging; Molecular Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radionuclide Imaging; Receptors, Somatostatin; Sensitivity and Specificity; Stomach Neoplasms; Surveys and Questionnaires; Tomography, X-Ray Computed; Ultrasonography | 2014 |
[New medical imaging based on electron tracking Compton camera (ETCC)].
Topics: 3-Iodobenzylguanidine; Animals; Electrons; Fluorodeoxyglucose F18; Gamma Cameras; Gamma Rays; Imaging, Three-Dimensional; Iodine Radioisotopes; Phantoms, Imaging; Radiation Monitoring; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, High-Energy; Scattering, Radiation; Water | 2012 |
Metastatic pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Mutation; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed | 2015 |
Radiology of the adrenal incidentalomas. Review of the literature.
Topics: 3-Iodobenzylguanidine; Addison Disease; Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenocortical Carcinoma; Cushing Syndrome; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Hemorrhage; Humans; Hyperaldosteronism; Indium; Indium Radioisotopes; Lymphoma; Magnetic Resonance Imaging; Myelolipoma; Octreotide; Pheochromocytoma; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2017 |
Neuroblastoma: MIBG Imaging and New Tracers.
Topics: 3-Iodobenzylguanidine; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radioactive Tracers; Radionuclide Imaging | 2017 |
Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
Topics: 3-Iodobenzylguanidine; Bone Marrow Neoplasms; Bone Neoplasms; Consensus; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Response Evaluation Criteria in Solid Tumors; Soft Tissue Neoplasms | 2017 |
Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography | 2018 |
The role of multimodality imaging in takotsubo cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Acute Coronary Syndrome; Cardiology; Cardiovascular Diseases; Echocardiography; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Magnetic Resonance Spectroscopy; Multimodal Imaging; Nuclear Medicine; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Takotsubo Cardiomyopathy; Ventricular Dysfunction, Left | 2019 |
Cystic adrenal masses: spectrum of multimodality imaging features and pathological correlation.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
Adrenal functional imaging - which marker for which indication?
Topics: 3-Iodobenzylguanidine; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Biomarkers; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Humans; Norepinephrine Plasma Membrane Transport Proteins; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Chemokine; Receptors, Somatostatin | 2022 |
3 trial(s) available for 3-iodobenzylguanidine and fluorodeoxyglucose f18
Article | Year |
---|---|
Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Contrast Media; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neuroblastoma; Tomography, Emission-Computed | 1996 |
Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
[11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Ephedrine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Single-Blind Method; Tissue Distribution; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
82 other study(ies) available for 3-iodobenzylguanidine and fluorodeoxyglucose f18
Article | Year |
---|---|
Fluorodeoxyglucose cell incorporation as an index of cell proliferation: evaluation of accuracy in cell culture.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bleomycin; Deoxyglucose; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Iodobenzenes; Tomography, Emission-Computed, Single-Photon; Tumor Cells, Cultured | 1993 |
Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Deoxyglucose; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Pheochromocytoma; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
PET hydroxyephedrine imaging of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adult; Carbon Radioisotopes; Child; Child, Preschool; Contrast Media; Deoxyglucose; Ephedrine; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Time Factors; Tomography, Emission-Computed | 1996 |
FDG PET imaging of paragangliomas of the neck: comparison with MIBG SPET.
Topics: 3-Iodobenzylguanidine; Adult; Carotid Body Tumor; Contrast Media; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glomus Jugulare Tumor; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
PET imaging of recurrent medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Carcinoma, Medullary; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Recurrence; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Thyroidectomy; Tomography, X-Ray Computed | 1996 |
Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pheochromocytoma; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Functional imaging of malignant paragangliomas and carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Paraganglioma; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2001 |
Role of molecular imaging in management of nonhypersecreting adrenal masses.
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2001 |
Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroblastoma; Radiopharmaceuticals; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
Paraganglioma seen with FDG dual-head gamma camera coincidence imaging after false-negative results of I-123 MIBG imaging.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
Metastases of predominantly dopamine-secreting phaeochromocytoma that did not accumulate meta-iodobenzylguanidine: imaging with whole body positron emission tomography using 18F-labelled deoxyglucose.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Pheochromocytoma; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
111In-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone and Bones; Bone Neoplasms; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neuroblastoma; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2002 |
Monitoring the efficacy of iodine-131-MIBG therapy using fluorine-18-FDG-PET.
Topics: 3-Iodobenzylguanidine; Biological Transport; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Radiopharmaceuticals; Reproducibility of Results; Tissue Distribution; Tomography, Emission-Computed | 2003 |
Case report: drug interference with MIBG uptake in a patient with metastatic paraganglioma.
Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Agents; Drug Interactions; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Methadone; Narcotics; Paraganglioma; Radiopharmaceuticals; Substance-Related Disorders; Tomography, Emission-Computed | 2004 |
MIBG and FDG PET findings in a patient with malignant pheochromocytoma: a significant discrepancy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites.
Topics: 3-Iodobenzylguanidine; Adult; Dopamine; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2006 |
Parkinsonism in type I Gaucher's disease.
Topics: 3-Iodobenzylguanidine; Adult; Age of Onset; Brain; Fluorodeoxyglucose F18; Gaucher Disease; Heart; Humans; Male; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2006 |
Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dopamine; Female; Fluorodeoxyglucose F18; Germ-Line Mutation; Humans; Iron-Sulfur Proteins; Male; Middle Aged; Neoplasm Metastasis; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Succinate Dehydrogenase | 2007 |
Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adipose Tissue, Brown; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Dopamine; Epinephrine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Norepinephrine; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2007 |
The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2007 |
Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D-glucose PET in a patient with thymic carcinoid.
Topics: 3-Iodobenzylguanidine; Aged; Bone Neoplasms; Carcinoid Tumor; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Thymus Neoplasms | 2007 |
Discrepancy between glucose metabolism and sympathetic nerve terminals in a patient with metastatic paraganglioma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adult; Blood Glucose; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Radionuclide Imaging; Sympathetic Nervous System | 2008 |
Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iron-Sulfur Proteins; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Retrospective Studies; Succinate Dehydrogenase; Tomography, Emission-Computed | 2008 |
The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2008 |
Value of combining activated brain FDG-PET and cardiac MIBG for the differential diagnosis of dementia: differentiation of dementia with Lewy bodies and Alzheimer disease when the diagnoses based on clinical and neuroimaging criteria are difficult.
Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart; Humans; Image Enhancement; Lewy Body Disease; Male; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Brown adipose tissue demonstrating intense FDG uptake in a patient with mediastinal pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adipose Tissue, Brown; Adrenal Gland Neoplasms; Adult; Bone Neoplasms; Catecholamines; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hypertension; Lymphatic Metastasis; Mediastinal Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.
Topics: 3-Iodobenzylguanidine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Neoplasm Recurrence, Local; Neoplasm, Residual; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Combined Modality Therapy; Endocrine Surgical Procedures; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Neoplasm Recurrence, Local; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed | 2009 |
Importance of inflammation and neurohumoral activation in Takotsubo cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; C-Reactive Protein; Case-Control Studies; Catecholamines; Coronary Circulation; Female; Fluorodeoxyglucose F18; Glucose; Humans; Leukocyte Count; Male; Myocardium; Natriuretic Peptide, Brain; Norepinephrine; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Takotsubo Cardiomyopathy; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Troponin I | 2009 |
123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Fluorodeoxyglucose F18; Humans; Male; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
[Case of 131I-meta-iodobenzylguanidine (MIBG) scintigraphy-negative and 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET)-positive pheochromocytoma].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Neuroblastoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2009 |
123I-MIBG versus 18F-FDG: which is better, or which can be eliminated?
Topics: 3-Iodobenzylguanidine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carney Complex; Chromogranin A; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Gene Transfer Techniques; Humans; Hypertension; Lymphatic Metastasis; Male; Metanephrine; Mutation; Neck; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Proto-Oncogene Proteins c-kit; Succinate Dehydrogenase; Syndrome; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2010 |
Diagnosis: imaging of pheochromocytomas and paragangliomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Contrast Media; Diagnostic Imaging; Dihydroxyphenylalanine; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed | 2010 |
Positron emission tomography with 18F-fluorodeoxyglucose is a useful tool for the diagnosis of pheochromocytomas without distant metastasis, where malignancy is suspected on the basis of histopathologic analysis.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Humans; Pheochromocytoma; Positron-Emission Tomography; Tomography, Emission-Computed | 2010 |
[Neuroblastoma staging: discrepancies between ¹⁸F-FDG-PET and ¹²³I-MIBG].
Topics: 3-Iodobenzylguanidine; Child; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |
Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
Topics: 3-Iodobenzylguanidine; Aged; Dominance, Cerebral; Early Diagnosis; Energy Metabolism; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gyrus Cinguli; Heart; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Iodine Radioisotopes; Lewy Body Disease; Male; Neuropsychological Tests; Occipital Lobe; Positron-Emission Tomography; Radionuclide Imaging; REM Sleep Behavior Disorder; Statistics as Topic; Sympathetic Nervous System; Temporal Lobe | 2010 |
18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Marrow Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Liver Neoplasms; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival; Survival Analysis; Tomography, Emission-Computed; Young Adult | 2011 |
¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Biological Transport; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Clinical significance of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography for the assessment of 131I-metaiodobenzylguanidine therapy in malignant phaeochromocytoma.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Biomarkers, Tumor; Catecholamines; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paraganglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Somatostatin; Succinate Dehydrogenase; Tomography, Emission-Computed | 2011 |
A pheochromocytoma with high adrenocorticotropic hormone and a silent lung nodule.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals | 2011 |
Glucose hypometabolism in primary visual cortex is commonly associated with clinical features of dementia with Lewy bodies regardless of cognitive conditions.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Visual Cortex | 2012 |
Contrast- and non-contrast-enhanced ultrasonography (US) findings of hepatic metastasis from malignant pheochromocytoma/paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Characterization of neuroblastic tumors using 18F-FDOPA PET.
Topics: 3-Iodobenzylguanidine; Biological Transport; Carboxy-Lyases; Catecholamines; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Vanilmandelic Acid | 2013 |
Combining 123I-metaiodobenzylguanidine SPECT/CT and 18F-FDG PET/CT for the assessment of brown adipose tissue activity in humans during cold exposure.
Topics: 3-Iodobenzylguanidine; Adipose Tissue, Brown; Adolescent; Adult; Anthropometry; Body Mass Index; Cold Temperature; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Norepinephrine; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Time Factors; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2013 |
Disparities in uptake pattern of (123)I-MIBG, (18)F-FDG, and (99m)Tc-MDP within the same primary neuroblastoma.
Topics: 3-Iodobenzylguanidine; Biological Transport; Child; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron-Emission Tomography; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2014 |
SDHB gene positive metastatic paraganglioma associated with lesions which demonstrate both positive and negative uptake of 18FDG PET and 131MIBG.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Fluorodeoxyglucose F18; Genotype; Humans; Ireland; Male; Paraganglioma; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase | 2013 |
Cold-induced activity of brown adipose tissue in young lean men of South-Asian and European origin.
Topics: 3-Iodobenzylguanidine; Adipose Tissue, Brown; Adolescent; Adult; Asia; Body Mass Index; Cold Temperature; Ethnicity; Europe; Fasting; Fluorodeoxyglucose F18; Glucose Clamp Technique; Humans; Insulin Resistance; Male; Positron-Emission Tomography; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2013 |
Impairment of cardiac metabolism and sympathetic innervation after aneurysmal subarachnoid hemorrhage: a nuclear medicine imaging study.
Topics: 3-Iodobenzylguanidine; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Intracranial Aneurysm; Iodine Radioisotopes; Myocardial Stunning; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Quality of Life; Radiopharmaceuticals; Rupture, Spontaneous; Subarachnoid Hemorrhage; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Troponin T | 2014 |
Cardioprotective effect of fimasartan, a new angiotensin receptor blocker, in a porcine model of acute myocardial infarction.
Topics: 3-Iodobenzylguanidine; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anterior Wall Myocardial Infarction; Biphenyl Compounds; Cardiotonic Agents; Disease Models, Animal; Echocardiography; Fluorodeoxyglucose F18; Perindopril; Positron-Emission Tomography; Pyrimidines; Random Allocation; Swine; Tetrazoles; Tomography, Emission-Computed, Single-Photon; Valsartan; Ventricular Function, Left | 2015 |
Incidental Acinic Cell Carcinoma of the Parotid Gland Discordant on 123I-MIBG, 111In-Octreotide, and 18F-FDG PET/CT in a Patient With Neuroendocrine Tumor of the Cecum.
Topics: 3-Iodobenzylguanidine; Carcinoma, Acinar Cell; Cecal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Parotid Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Asymptomatic Diseases; Female; Fluorodeoxyglucose F18; Heterozygote; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Mutation; Pedigree; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed | 2015 |
Comparison of 131I-MIBG, 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT scans in a patient with extra adrenal paraganglioma associated with SDH-B gene mutation.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Mutation; Organometallic Compounds; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed | 2015 |
Mediastinal paraganglioma.
Topics: 3-Iodobenzylguanidine; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mediastinal Neoplasms; Middle Aged; Paraganglioma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Radiopharmaceuticals in paraganglioma imaging: too many members on board?
Topics: 3-Iodobenzylguanidine; Algorithms; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Mutation; Paraganglioma; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Succinate Dehydrogenase | 2016 |
Weak uptake of 123I-MIBG and 18F-FDOPA contrasting with high 18F-FDG uptake in stage I neuroblastoma.
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Differences in Sympathetic Nervous Stimulation of Brown Adipose Tissue Between the Young and Old, and the Lean and Obese.
Topics: 3-Iodobenzylguanidine; Adipose Tissue, Brown; Adult; Aging; Body Weight; Cold Temperature; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Obesity; Overweight; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sympathetic Nervous System; Waist Circumference; Young Adult | 2016 |
Abnormal FDG and MIBG Activity in the Bones in a Patient With Neuroblastoma Without Detectable Primary Tumor.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child, Preschool; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Unknown Primary; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy.
Topics: 3-Iodobenzylguanidine; Brain; Chorea; Corpus Striatum; Cysteine; Diabetes Complications; Diabetes Mellitus; Dopamine; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Neostriatum; Nortropanes; Organotechnetium Compounds; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Substantia Nigra; Tomography, Emission-Computed, Single-Photon | 2016 |
Seasonal influence on stimulated BAT activity in prospective trials: a retrospective analysis of BAT visualized on 18F-FDG PET-CTs and 123I-mIBG SPECT-CTs.
Topics: 3-Iodobenzylguanidine; Adipose Tissue, Brown; Adolescent; Adult; Aged; Body Mass Index; Cold Temperature; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Seasons; Temperature; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2016 |
Multiple Neoplasms Simultaneously Diagnosed by Complementary Triple-Tracer PET/CT and 123I-MIBG Scintigraphy.
Topics: 3-Iodobenzylguanidine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Multiple Primary; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Multiple Endocrine Neoplasia Type 2B Unmasked by 18 F-FDG PET/CT and 131 I-MIBG SPECT/CT.
Topics: 3-Iodobenzylguanidine; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Multiple Endocrine Neoplasia Type 2b; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Thyroid Neoplasms | 2017 |
Comparison of the 68Ga-DOTATATA PET/CT, FDG PET/CT, and MIBG SPECT/CT in the Evaluation of Suspected Primary Pheochromocytomas and Paragangliomas.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography | 2017 |
Neuroblastoma Presenting as Non-MIBG-Avid Widespread Soft Tissue Metastases Without Bone Involvement Revealed by FDG PET/CT Imaging.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron Emission Tomography Computed Tomography; Soft Tissue Neoplasms | 2017 |
Functional brown adipose tissue and sympathetic activity after cold exposure in humans with type 1 narcolepsy.
Topics: 3-Iodobenzylguanidine; Adipose Tissue, Brown; Adult; Cold Temperature; Female; Fibroblast Growth Factors; Fluorodeoxyglucose F18; Glucagon-Like Peptide 1; Healthy Volunteers; Humans; Male; Middle Aged; Narcolepsy; Orexins; Positron-Emission Tomography; Thermogenesis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2018 |
18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Male; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Young Adult | 2019 |
Radiation-induced myocardial damage indicated by focal defect on
Topics: 3-Iodobenzylguanidine; Echocardiography; Female; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Iodine Radioisotopes; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Radiation Injuries; Tomography, Emission-Computed, Single-Photon | 2019 |
Recurrence of a Pheochromocytoma With TNEM127 Mutation Negative on 18F-FDOPA and 18F-FDG but Positive on 123I-MIBG and 68Ga-DOTATOC Imaging.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Mutation; Octreotide; Organometallic Compounds; Pheochromocytoma; Positron Emission Tomography Computed Tomography | 2022 |
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2022 |
Asphericity of tumor [
Topics: 3-Iodobenzylguanidine; Adult; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; N-Myc Proto-Oncogene Protein; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2022 |
Prognostic value of [
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Glycolysis; Humans; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2023 |
Occipital hypometabolism is a risk factor for conversion to Parkinson's disease in isolated REM sleep behaviour disorder.
Topics: 3-Iodobenzylguanidine; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography; REM Sleep Behavior Disorder; Risk Factors | 2023 |